0001104659-15-051249.txt : 20150715
0001104659-15-051249.hdr.sgml : 20150715
20150715153823
ACCESSION NUMBER: 0001104659-15-051249
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150715
DATE AS OF CHANGE: 20150715
EFFECTIVENESS DATE: 20150715
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 15989291
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
06-30-2015
06-30-2015
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
(415) 801-8100
/s/ Robin L. Praeger
San Francisco
CA
07-14-2015
0
5
78844234
false
INFORMATION TABLE
2
a15-15704_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
35803718
407416
SH
OTR
0
407416
0
Five Prime Therapeutics, Inc.
Common Stock
33830X104
27129055
1092152
SH
OTR
0
1092152
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
2820736
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
7725346
1281152
SH
OTR
0
1281152
0
Biotie Therapies Corp.
ADS
09074D103
5365379
268672
SH
OTR
0
268672
0